Vincerx Pharma (VINC) on Friday filed a mixed shelf registration statement to raise up to $100 million from the potential sale of several securities from time to time.
The filing covers debt securities, common shares, preferred shares, depositary shares, warrants and rights, the company said.
Net proceeds will be for general corporate purposes, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.